Combating the burden of musculoskeletal conditionsSMOLEN, J. S.Annals of the rheumatic diseases. 2004, Vol 63, Num 4, issn 0003-4967, p. 329Article

DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseALETAHA, D; SMOLEN, J. S.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S169-S173, issn 0392-856X, SUP31Article

The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD coursesALETAHA, D; SMOLEN, J. S.Rheumatology (Oxford. Print). 2002, Vol 41, Num 12, pp 1367-1374, issn 1462-0324, 8 p.Article

Mixed connective tissue disease : To be or not to be?SMOLEN, J. S; STEINER, G.Arthritis and rheumatism. 1998, Vol 41, Num 5, pp 768-777, issn 0004-3591Article

Patients with rheumatoid arthritis in clinical careSMOLEN, J. S; ALELAHA, D.Annals of the rheumatic diseases. 2004, Vol 63, Num 3, pp 221-225, issn 0003-4967, 5 p.Article

Early arthritisPINCUS, T; SMOLEN, J. S.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, issn 0392-856X, 211 p., SUP31Serial Issue

Neue Autoantikörper in der Diagnostik der rheumatoiden Arthritis = Novel autoantibodies for the diagnosis of rheumatoid arthritisSTEINER, G; SMOLEN, J. S.Zeitschrift für Rheumatologie (Print). 2002, Vol 61, Num 6, pp 667-673, issn 0340-1855, 7 p.Article

Treat-to-target: rationale and strategiesSMOLEN, J. S.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S2-S6, SUP73Article

Efficacy and safety of leflunomide in active rheumatoid arthritisSMOLEN, J. S; EMERY, P.Rheumatology (Oxford. Print). 2000, Vol 39, Num JUN, pp 48-56, issn 1462-0324, SUPArticle

The French early arthritis registryCOMBE, B.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S123-S128, issn 0392-856X, SUP31Article

Pharmacoeconomics of drug therapy for rheumatoid arthritisTUGWELL, P.Rheumatology (Oxford. Print). 2000, Vol 39, Num JUN, pp 43-47, issn 1462-0324, SUPArticle

Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formationSCHETT, G; STEINER, G; SMOLEN, J. S et al.Arthritis and rheumatism. 1998, Vol 41, Num 8, pp 1446-1455, issn 0004-3591Article

The treatment of rheumatoid arthritis in this century : From spas to monoclonal antibodiesPASERO, G.Clinical and experimental rheumatology (Testo stampato). 1997, Vol 15, pp S67-S70, issn 0392-856X, SUP17Article

Anti-RA 33 : a new autoantibody characteristics of rheumatoid arthritisSMOLEN, J. S; HASSFELD, W; STEINER, G et al.Israel journal of medical sciences. 1990, Vol 26, Num 12, pp 693-694, issn 0021-2180Conference Paper

Early arthritis clinic: A USA perspectiveCUSH, J. J.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S75-S78, issn 0392-856X, SUP31Article

Future trends in the management of rheumatoid arthritisWEISMAN, M. H; SMOLEN, J. S.Rheumatology (Oxford. Print). 1999, Vol 38, issn 1462-0324, 55 p., SUP2Serial Issue

Severe infections in plasmapheresis-treated systemic lupus erythematosusARINGER, M; SMOLEN, J. S; GRANINGER, W. B et al.Arthritis and rheumatism. 1998, Vol 41, Num 3, pp 414-420, issn 0004-3591Article

Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex : Novel tools for the diagnosis of rheumatic diseases : Diagnostic and therapeutic aspects of connective tissue diseaseSTEINER, G; SKRINER, K; SMOLEN, J. S et al.International archives of allergy and immunology. 1996, Vol 111, Num 4, pp 314-319, issn 1018-2438Article

Similar frequency of autoantibodies against 70-kD class heat-shock proteins in healthy subjects and systemic lupus erythematosus patientsKINDÅS-MÜGGE, I; STEINER, G; SMOLEN, J. S et al.Clinical and experimental immunology (Print). 1993, Vol 92, Num 1, pp 46-50, issn 0009-9104Article

The assessment of disease activity in rheumatoid arthritisSMOLEN, J. S; ALETAHA, D.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 3, issn 0392-856X, S18-S27, SUP59Article

Does damage cause inflammation? Revisiting the link between joint damage and inflammationSMOLEN, J. S; ALETAHA, D; STEINER, G et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 2, pp 159-162, issn 0003-4967, 4 p.Article

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritisALETAHA, D; KAPRAL, T; SMOLEN, J. S et al.Annals of the rheumatic diseases. 2003, Vol 62, Num 5, pp 482-486, issn 0003-4967, 5 p.Article

Functional disability and quality-of-life assessment in clinical practiceGUILLEMIN, F.Rheumatology (Oxford. Print). 2000, Vol 39, Num JUN, pp 17-23, issn 1462-0324, SUPArticle

Recombinant human interferon γ in the treatment of rheumatoid arthritis : double blind placebo controlled studyMACHOLD, K. P; NEUMANN, K; SMOLEN, J. S et al.Annals of the rheumatic diseases. 1992, Vol 51, Num 9, pp 1039-1043, issn 0003-4967Article

Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteriaClinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S129-S132, issn 0392-856X, SUP31Article